by Susie Hoffman
I’m writing to tell you about one of PRIM&R’s little-known membership benefits: PRIM&R Regional Connections.
I first took advantage of this benefit in 2007 to convene the inaugural Virginia Institutional Review Board (IRB) Consortium conference. My goal was to provide a low-cost education and networking opportunity to IRBs throughout Virginia. The Virginia IRB Consortium conference has blossomed into an annual event. I cherish the sense of community that this event brings. It is always wonderful to make connections with new colleagues and to watch their eyes light up as they realize they have found others that actually know what an IRB [...] Read more
by Emily A. Largent and Alan Wertheimer, PhD
How do institutional review board (IRB) members and human research protections professionals think about the relationship between payment, coercion, and undue influence?
This is a topic of obvious interest to the research community: Researchers routinely offer payment to prospective research participants as an incentive to enroll or as compensation for their participation in research. IRBs are, in turn, asked to review these payments for their ethical implications. Yet, there is little systematic data about attitudes toward payment in general, and specifically, when IRB members consider payment coercion or undue influence.
To address these questions, in 2010, we surveyed randomly selected PRIM&R [...] Read more
Oluyemisi Akinwande, a 2009 Advancing Ethical Research Conference scholar, remarks on what she learned at the conference, and shares updates on how her experiences have influenced her work at home in Nigeria.
I became familiar with PRIM&R’s AER Conference in an interesting way; in the midst of clearing away some old papers, I stumbled on one that had information on a research ethics meeting being held in Nashville, TN. I found the prospect exciting; I had never heard of, or attended, a conference on ethics before!
In light of research ethics being a key component [...] Read more
by Wendy Tate, PSM, CIP
By this time almost everyone is familiar with the advance notice of proposed rulemaking (ANPRM) that recommends vast changes to the human subject regulations known as the “Common Rule.” As I read the memorandum, table of changes, and 92-page document, one thing kept popping into my mind: What about the subparts?
Being “in the trenches” at a university that supports both medical and social/behavioral research, I find it frustrating to apply subpart B (research involving pregnant women) to non-biomedical research and/or minimal risk biomedical research. Granted, subpart B is not technically part of the “Common Rule,” and as such is not included in the recent ANPRM. [...] Read more
by Victoria Pemberton, RNC, MS, CCRC
clinical trials specialist, National Heart, Lung, and Blood Institute
“The PHS Syphilis Study, Guatemala, Willowbrook, radiation experiments…” Despite decades of work to improve the safety of research subjects, these words bring to mind images of fear and the mistreatment of potential research participants, including children.
Excellence in research is essential to our health and quality of life. While many potential participants recognize the need for clinical studies, they continue to shy away from participating. The perceptions surrounding pediatric research can be even more challenging and exist not only among parents, but among healthcare providers as well. Consider these facts:
- Ninety-five percent of adults support studying [...] Read more